NASDAQ · ONCO
Onconetix, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ONCO: Nov 12, 2026
Onconetix, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-99.99.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · InvestorPlace- RTTNews · Dec 18, 8:00 AM ESTBlue Water Biotech Acquires Proteomedix AG(RTTNews) – Blue Water Biotech, Inc. (BWV) on Monday announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology company, and stated that the combined company will operate under the name Onconetix, Inc (Nasdaq: ONCO).
- Zacks · Jun 15, 9:37 AM EDTBlue Water (BWV) Up on Acquisition of 6 FDA-Approved DrugsBlue Water Biotech BWV announced the signing of an Asset Purchase Agreement with WraSer, LLC and Xspire Pharma, LLC. Shares of BWV surged 62% on Jun 14, following the news.
- RTTNews · Aug 30, 7:11 AM EDTPre-market Movers: MGAM, SNTG, FREY, BBBY, ABSI…(RTTNews) – The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.05 A.M. ET).
- RTTNews · Aug 18, 7:57 AM EDTPre-market Movers: BRSH, CDAK, BWV, WOLF, AVGR…(RTTNews) – The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.50 A.M. ET).
- InvestorPlace · Aug 16, 4:28 PM EDT7 Short-Squeeze Stocks to Put on Your Must-Watch ListInvestorPlace – Stock Market News, Stock Advice & Trading Tips
- RTTNews · May 4, 7:56 AM EDTPre-market Movers: LYFT, ACON, LTHM, IMMP, BWV…(RTTNews) – The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET).
- RTTNews · Apr 12, 7:08 AM EDTPre-market Movers: BDSX, AGLE, VERU, CJJD, HYRE…(RTTNews) – The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.00 A.M. ET).
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Onconetix, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.